{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T04:37:15Z","timestamp":1766378235014},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,6]]},"DOI":"10.7759\/cureus.10277","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T17:48:31Z","timestamp":1599414511000},"source":"Crossref","is-referenced-by-count":2,"title":["Nilotinib-Induced Diabetes Mellitus in a Young Female with Chronic Myeloid Leukemia"],"prefix":"10.7759","author":[{"given":"Abdel-Latif S","family":"Ismail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16599","article-title":"TARGET: a survey of real\u2010world management of chronic myeloid leukaemia across 33 countries","volume":"[Epub ahead of print]","author":"Turkina A","year":"2020","unstructured":"Turkina A, Wang J, Mathews V, et al.. TARGET: a survey of real\u2010world management of chronic myeloid leukaemia across 33 countries. Br J Haematol. 2020, [Epub ahead of print]:10.1111\/bjh.16599","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5339\/connect.2014.24","article-title":"Molecular monitoring of patients with chronic myeloid leukemia (CML) in the state of Qatar: optimization of techniques and response to imatinib","volume":"1","author":"Al-Dewik NI","year":"2014","unstructured":"Al-Dewik NI, Jewell AP, Yassin MA, El-Ayoubi HR, Morsi HM. Molecular monitoring of patients with chronic myeloid leukemia (CML) in the state of Qatar: optimization of techniques and response to imatinib. QSci Connect. 2014, 1:[Epub]. 10.5339\/connect.2014.24","journal-title":"QSci Connect"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0494-z","article-title":"A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type \u03b3 in chronic myeloid leukemia patients","volume":"10","author":"Vezzalini M","year":"2017","unstructured":"Vezzalini M, Mafficini A, Tomasello L, et al.. A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type \u03b3 in chronic myeloid leukemia patients. J Hematol Oncol. 2017, 10:129. 10.1186\/s13045-017-0494-z","journal-title":"J Hematol Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-126622","article-title":"Chronic myeloid leukemia in adolescents and young adults: a single institute experience","volume":"134","author":"Yassin MA","year":"2019","unstructured":"Yassin MA, Abdulla MA, Chandra P, Aldapt MB, Hamad Y. Chronic myeloid leukemia in adolescents and young adults: a single institute experience. Blood. 2019, 134:5915-5915. 10.1182\/blood-2019-126622","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.086355","article-title":"Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia","volume":"98","author":"Racil Z","year":"2013","unstructured":"Racil Z, Razga F, Drapalova J, et al.. Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia. Haematologica. 2013, 98:124-126. 10.3324\/haematol.2013.086355","journal-title":"Haematologica"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Michele B","year":"2013","unstructured":"Michele B, Michael W D, Gianantonio R, et al.. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. 2013, 122:872-884. 10.1182\/blood-2013-05-501569","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4137\/CMO.S32822","article-title":"Is adherence to imatinib mesylate treatment among patients with chronic myeloid leukemia associated with better clinical outcomes in Qatar?","volume":"10","author":"Al-Dewik NI","year":"2016","unstructured":"Al-Dewik NI, Morsi HM, Samara MM, et al.. Is adherence to imatinib mesylate treatment among patients with chronic myeloid leukemia associated with better clinical outcomes in Qatar?. Clin Med Insights Oncol. 2016, 10:32822. 10.4137\/CMO.S32822","journal-title":"Clin Med Insights Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-121833","article-title":"Dasatinib and nilotinib as upfront therapy for chronic-phase chronic myeloid leukemia (CML-CP) in Qatar: a cost effectiveness analysis (CEA)","volume":"134","author":"Ahmad AM","year":"2019","unstructured":"Ahmad AM, Abushanab D, Hamad A, Abdulla MAJ, Yassin MA. Dasatinib and nilotinib as upfront therapy for chronic-phase chronic myeloid leukemia (CML-CP) in Qatar: a cost effectiveness analysis (CEA). Blood. 2019, 134:5850. 10.1182\/blood-2019-121833","journal-title":"Blood"},{"key":"ref9","article-title":"Cutaneous manifestations of nilotinib","volume":"3","author":"Yassin MA","year":"2018","unstructured":"Yassin MA, Mudawi D, Nashwan A, Kassem N. Cutaneous manifestations of nilotinib.  Int J Blood Res Disord. 2018, 3:1-3.","journal-title":"Int J Blood Res Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4137\/CCRep.S25327","article-title":"Cytomegalovirus-induced hemorrhagic colitis in a patient with chronic myeloid leukemia (chronic phase) on dasatinib as an upfront therapy","volume":"8","author":"Yassin MA","year":"2015","unstructured":"Yassin MA, Nashwan AJ, Soliman AT, et al.. Cytomegalovirus-induced hemorrhagic colitis in a patient with chronic myeloid leukemia (chronic phase) on dasatinib as an upfront therapy. Clin Med Insights Case Rep. 2015, 8:25327. 10.4137\/CCRep.S25327","journal-title":"Clin Med Insights Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4137\/CMBD.S24628","article-title":"Dasatinib induced avascular necrosis of femoral head in adult patient with chronic myeloid leukemia","volume":"8","author":"Yassin MA","year":"2015","unstructured":"Yassin MA, Moustafa AH, Nashwan AJ, et al.. Dasatinib induced avascular necrosis of femoral head in adult patient with chronic myeloid leukemia. Clin Med Insights Blood Disord. 2015, 8:24628. 10.4137\/CMBD.S24628","journal-title":"Clin Med Insights Blood Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-012-1222-7","article-title":"Nilotinib exacerbates diabetes mellitus by decreasing secretion of endogenous insulin","volume":"97","author":"Ito Y","year":"2013","unstructured":"Ito Y, Miyamoto T, Chong Y, Maki T, Akashi K, Kamimura T. Nilotinib exacerbates diabetes mellitus by decreasing secretion of endogenous insulin. Int J Hematol. 2013, 97:135-138. 10.1007\/s12185-012-1222-7","journal-title":"Int J Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5580","article-title":"Effects of first-and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem?","volume":"6","author":"Iurlo A","year":"2015","unstructured":"Iurlo A, Orsi E, Cattaneo D, et al.. Effects of first-and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem?. Oncotarget. 2015, 6:33944-33951. 10.18632\/oncotarget.5580","journal-title":"Oncotarget"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/37788-nilotinib-induced-diabetes-mellitus-in-a-young-female-with-chronic-myeloid-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:01Z","timestamp":1707506761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/37788-nilotinib-induced-diabetes-mellitus-in-a-young-female-with-chronic-myeloid-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,6]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.10277","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,6]]}}}